OneMedNet Reports 88% Revenue Growth in Q2 2026, Faces $2.2 Million Net Loss

OneMedNet Corporation reported its financial results for the second quarter of 2026, revealing a total revenue of $292,000, a significant increase of 88% compared to $155,000 in the same period of 2025. The growth was primarily driven by a rise in data delivery revenue, which reached $292,000, up from $108,000 a year earlier. However, the company did not generate any subscription revenue during the quarter, a decline from $47,000 in the previous year, attributed to the decommissioning of its BEAM platform in May 2025. The company incurred a net loss of $2.2 million for the quarter, compared to a net income of $3.0 million in the prior year, reflecting a substantial shift in profitability.

For the first half of 2026, OneMedNet's total revenue was $388,000, a 33% increase from $292,000 in the first half of 2025. The increase in revenue was again driven by data delivery services, while subscription revenue fell to zero from $105,000. The company's operating expenses for the first half of 2026 totaled $3.7 million, down from $3.9 million in the same period last year, primarily due to reduced general and administrative costs. Despite the decrease in expenses, the company reported a net loss of $4.6 million for the six months ended June 30, 2026, compared to a net income of $1.1 million in the prior year.

In terms of operational developments, OneMedNet's customer base and engagement metrics showed positive trends, with increased adoption of its iRWD platform contributing to higher data delivery volumes. The company has also been actively involved in raising capital, securing approximately $2.1 million from related party subscription agreements and $1.0 million from its Standby Equity Purchase Agreement (SEPA) during the first half of 2026. As of June 30, 2026, OneMedNet had 59,286,450 shares of common stock outstanding, reflecting ongoing efforts to bolster its financial position.

The company has faced challenges, including a significant accumulated deficit of $109 million as of June 30, 2026, and a cash balance of $358,000, which is insufficient to fund operations for the next twelve months. OneMedNet's management has indicated plans to raise additional capital through equity or debt offerings to support its operations and growth strategy. The company is also navigating compliance issues with Nasdaq regarding its stock price, which has fallen below the required minimum bid price.

Looking ahead, OneMedNet's management remains focused on enhancing its operational capabilities and expanding its market presence. The company is committed to improving its financial health and achieving profitability, although it acknowledges the uncertainties and risks associated with its business model and market conditions. The outlook for the remainder of 2026 will depend on the successful execution of its strategic initiatives and the ability to secure necessary funding.